Gregor Lindner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gregor Lindner has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
Svenja Ravioli
Department of Emergency Medicine, Kepler University Hospital, Johannes Kepler University Linz, Austria
18 shared publicationsChristoph Schwarz
Department of Internal Medicine, Pyhrn-Eisenwurzen Klinikum Steyr, Austria
16 shared publicationsAristomenis K. Exadaktylos
Department of Emergency Medicine, Inselspital, University Hospital Bern, Switzerland
13 shared publications- Carmen Andrea Pfortmueller
Department of Intensive Care Inselspital, Bern University Hospital and University of Bern Bern Switzerland
12 shared publications Georg-Christian Funk
Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology, Klinik Ottakring, Vienna, Austria
9 shared publicationsWilfred Druml
5 shared publications
Latest Publications
- 24 July 2026
- Published by Wiley in Hemodialysis International
Longitudinal Changes in Acid–Base Parameters From Dialysis Initiation to Death in Maintenance Hemodialysis Patients
Introduction: Blood gas analysis is routinely performed in hemodialysis patients to monitor acid–base status and serum potassium. Despite frequent testing, longitudinal analyses of acid–base parameters over patients' lifetime are lacking. Methods: We conducted a retrospective analysis of 45 chronic hemodialysis patients at a secondary dialysis center in Austria, including 7946 blood gas analyses. Acid–base disturbances and respiratory compensation to metabolic acidosis were evaluated. Longitudinal changes were assessed at three time points: START (4 weeks after dialysis initiation), MID (mid‐survival), and EOL (last 4 weeks of dialysis). Four measurements per patient were included at each time point. Venous blood gas values were adjusted to arterial equivalents to improve comparability. Linear mixed‐effects models were used for analysis. Findings: Venous blood gas analysis systematically misclassified respiratory status; standard formulas for compensation (e.g., Winter's formula) were not applicable. Over the course of dialysis treatment, acid–base and electrolyte homeostasis changed significantly. Temporal patterns were largely comparable between expected and unexpected death, with the exception of lactate, which increased significantly in patients with unexpected death. Discussion: This study provides a comprehensive longitudinal evaluation of acid–base parameters from dialysis initiation to death. Observed temporal patterns, particularly in patients with unexpected death, suggest distinct terminal metabolic trajectories. These findings warrant further investigation in larger cohorts, potentially supported by artificial intelligence‐based analyses.
- 24 July 2026
- Published by Wiley in Hemodialysis International
Longitudinal Changes in Acid–Base Parameters From Dialysis Initiation to Death in Maintenance Hemodialysis Patients
Introduction: Blood gas analysis is routinely performed in hemodialysis patients to monitor acid–base status and serum potassium. Despite frequent testing, longitudinal analyses of acid–base parameters over patients' lifetime are lacking. Methods: We conducted a retrospective analysis of 45 chronic hemodialysis patients at a secondary dialysis center in Austria, including 7946 blood gas analyses. Acid–base disturbances and respiratory compensation to metabolic acidosis were evaluated. Longitudinal changes were assessed at three time points: START (4 weeks after dialysis initiation), MID (mid‐survival), and EOL (last 4 weeks of dialysis). Four measurements per patient were included at each time point. Venous blood gas values were adjusted to arterial equivalents to improve comparability. Linear mixed‐effects models were used for analysis. Findings: Venous blood gas analysis systematically misclassified respiratory status; standard formulas for compensation (e.g., Winter's formula) were not applicable. Over the course of dialysis treatment, acid–base and electrolyte homeostasis changed significantly. Temporal patterns were largely comparable between expected and unexpected death, with the exception of lactate, which increased significantly in patients with unexpected death. Discussion: This study provides a comprehensive longitudinal evaluation of acid–base parameters from dialysis initiation to death. Observed temporal patterns, particularly in patients with unexpected death, suggest distinct terminal metabolic trajectories. These findings warrant further investigation in larger cohorts, potentially supported by artificial intelligence‐based analyses.
- Open Access
- 1 July 2026
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 156 (7) , 5135
Severe acidaemia in the emergency department: a retrospective cohort study
OBJECTIVES: Analysis of acid-base status is crucial for diagnosing and treating underlying disorders. There is a scarcity of data on causes of severe acidosis in emergency patients. The current analysis aimed to evaluate the cause of severe acidaemia on admission to an emergency department by using the physical-chemical approach as simplified by Story. Moreover, we evaluated the outcome of patients with severe acidaemia on admission to the emergency department in terms of hospitalisation, length of hospital stay, ICU admission and in-hospital mortality. METHODS: The retrospective analysis included all adult patients presenting to the Emergency Department of Kepler University Hospital Linz, Austria, with a pH 45 mm Hg, while respiratory alkalosis was defined as pCO2 <35 mm Hg. Analysis of metabolic components was performed using Story’s simplified approach. RESULTS: The study included 79 patients with severe acidaemia (pH <7.15). Median pH was 7.08 (interquartile range [IQR]: 7.04–7.11) with a minimum of 6.78. The pCO2 was 41 mm Hg / 5.47 kPa (IQR: 33–78 mm Hg / 4.4–10.4 kPa) with a minimum of 13/1.73 and a maximum of 164/21.86. Median standard bicarbonate was 11 mmol/l (IQR: 8–17) with a minimum of 3.9. Median base excess was –16.3 mmol/l (IQR: –21.85 – –5.75) with a minimum of –29.7. Median lactate was 3.6 mmol/l (IQR: 1.8–8.8). Primary respiratory acidosis was present in 49% of patients, while 51% had primary metabolic acidosis. 58% of patients with primary metabolic acidosis had a combination of strong ion difference-associated and unmeasured-anion (UMA) acidosis. The main causes of UMA acidosis were lactic acidosis, diabetic ketoacidosis and uraemia. CONCLUSION: Severe acidaemia is caused equally by primary respiratory and metabolic acidoses. Combinations of different mechanisms leading to severe acidaemia are common and can potentially mask therapeutically relevant acid-base disorders such as diabetic ketoacidosis.
- 1 July 2026
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 156 (7) , 5135
Open AccessSevere acidaemia in the emergency department: a retrospective cohort study
OBJECTIVES: Analysis of acid-base status is crucial for diagnosing and treating underlying disorders. There is a scarcity of data on causes of severe acidosis in emergency patients. The current analysis aimed to evaluate the cause of severe acidaemia on admission to an emergency department by using the physical-chemical approach as simplified by Story. Moreover, we evaluated the outcome of patients with severe acidaemia on admission to the emergency department in terms of hospitalisation, length of hospital stay, ICU admission and in-hospital mortality. METHODS: The retrospective analysis included all adult patients presenting to the Emergency Department of Kepler University Hospital Linz, Austria, with a pH 45 mm Hg, while respiratory alkalosis was defined as pCO2 <35 mm Hg. Analysis of metabolic components was performed using Story’s simplified approach. RESULTS: The study included 79 patients with severe acidaemia (pH <7.15). Median pH was 7.08 (interquartile range [IQR]: 7.04–7.11) with a minimum of 6.78. The pCO2 was 41 mm Hg / 5.47 kPa (IQR: 33–78 mm Hg / 4.4–10.4 kPa) with a minimum of 13/1.73 and a maximum of 164/21.86. Median standard bicarbonate was 11 mmol/l (IQR: 8–17) with a minimum of 3.9. Median base excess was –16.3 mmol/l (IQR: –21.85 – –5.75) with a minimum of –29.7. Median lactate was 3.6 mmol/l (IQR: 1.8–8.8). Primary respiratory acidosis was present in 49% of patients, while 51% had primary metabolic acidosis. 58% of patients with primary metabolic acidosis had a combination of strong ion difference-associated and unmeasured-anion (UMA) acidosis. The main causes of UMA acidosis were lactic acidosis, diabetic ketoacidosis and uraemia. CONCLUSION: Severe acidaemia is caused equally by primary respiratory and metabolic acidoses. Combinations of different mechanisms leading to severe acidaemia are common and can potentially mask therapeutically relevant acid-base disorders such as diabetic ketoacidosis.
- Open Access
- 13 April 2026
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 138 (21-22) , 673-677
Comparison of sodium and potassium measurements in the emergency department by point-of-care vs. central laboratory testing
Summary: Background: Point-of-care testing (POCT) using blood gas analyzers provides rapid results and can reduce diagnostic delays. Discrepancies between POCT and central laboratory (CL) measurements have been observed, particularly in patients with sodium disorders. This study evaluated the agreement between POCT and CL measurements for sodium and potassium in patients with hyponatremia, normonatremia and hypernatremia. Methods: In this retrospective single-center analysis, all paired measurements of sodium and potassium performed by POCT (Radiometer ABL 90 Flex Plus) and the CL (Roche Cobas Pro ISE) within ± 2 h between January and December 2024 were included. The correlation, Bland-Altman analysis, paired tests and intraclass correlation coefficients (ICC) were used to assess agreement. Regression analysis evaluated proportional bias and ANOVA tested differences among dysnatremic and normonatremic groups. Results: A total of 6404 paired sodium and 5622 paired potassium measurements were analyzed. Sodium was 140.3 mmol/L (SD 4.5) (POCT) and 137.8 mmol/L (SD 6.6) (CL), showing a mean difference of 2.4 mmol/L (SD 1.5). The correlation was significant (r = 0.583, p < 0.001) but ICC indicated poor agreement (0.473). The ANOVA demonstrated statistically significant differences between sodium groups ( p = 0.007, effect size 0.002), indicating more pronounced deviations in hypernatremic patients. For potassium, the mean difference was 0.12 mmol/L (interquartile range, IQR 0.05–0.22 mmol/L) with good agreement (ICC = 0.85) but a significant proportional bias ( p < 0.001). Clinically relevant deviations (> 4 mmol/L sodium or > 0.5 mmol/L potassium) occurred in 8.5% and 4.5% of cases, respectively. Conclusion: While potassium showed a very strong correlation and good agreement, sodium demonstrated only moderate correlation and poor agreement according to ICC criteria. Systematic and clinically relevant deviations were frequent, particularly in dysnatremic and dyskalemic patients.
- 13 April 2026
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 138 (21-22) , 673-677
Open AccessComparison of sodium and potassium measurements in the emergency department by point-of-care vs. central laboratory testing
Summary: Background: Point-of-care testing (POCT) using blood gas analyzers provides rapid results and can reduce diagnostic delays. Discrepancies between POCT and central laboratory (CL) measurements have been observed, particularly in patients with sodium disorders. This study evaluated the agreement between POCT and CL measurements for sodium and potassium in patients with hyponatremia, normonatremia and hypernatremia. Methods: In this retrospective single-center analysis, all paired measurements of sodium and potassium performed by POCT (Radiometer ABL 90 Flex Plus) and the CL (Roche Cobas Pro ISE) within ± 2 h between January and December 2024 were included. The correlation, Bland-Altman analysis, paired tests and intraclass correlation coefficients (ICC) were used to assess agreement. Regression analysis evaluated proportional bias and ANOVA tested differences among dysnatremic and normonatremic groups. Results: A total of 6404 paired sodium and 5622 paired potassium measurements were analyzed. Sodium was 140.3 mmol/L (SD 4.5) (POCT) and 137.8 mmol/L (SD 6.6) (CL), showing a mean difference of 2.4 mmol/L (SD 1.5). The correlation was significant (r = 0.583, p < 0.001) but ICC indicated poor agreement (0.473). The ANOVA demonstrated statistically significant differences between sodium groups ( p = 0.007, effect size 0.002), indicating more pronounced deviations in hypernatremic patients. For potassium, the mean difference was 0.12 mmol/L (interquartile range, IQR 0.05–0.22 mmol/L) with good agreement (ICC = 0.85) but a significant proportional bias ( p < 0.001). Clinically relevant deviations (> 4 mmol/L sodium or > 0.5 mmol/L potassium) occurred in 8.5% and 4.5% of cases, respectively. Conclusion: While potassium showed a very strong correlation and good agreement, sodium demonstrated only moderate correlation and poor agreement according to ICC criteria. Systematic and clinically relevant deviations were frequent, particularly in dysnatremic and dyskalemic patients.
- Open Access
- 9 January 2026
- Published by Elsevier in The American Journal of Medicine
- Vol. 139 (4) , 495-499
Non-hyponatremia-associated osmotic demyelination syndrome: an analysis of published cases
- 9 January 2026
- Published by Elsevier in The American Journal of Medicine
- Vol. 139 (4) , 495-499
Open AccessNon-hyponatremia-associated osmotic demyelination syndrome: an analysis of published cases
- Open Access
- 19 April 2025
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 94, 46-49
Performance of the artificial intelligence-based Swiss medical assessment system versus Manchester triage system in the emergency department: A retrospective analysis
- 19 April 2025
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 94, 46-49
Open AccessPerformance of the artificial intelligence-based Swiss medical assessment system versus Manchester triage system in the emergency department: A retrospective analysis
- 9 March 2023
- Published by Elsevier in The American Journal of Medicine
- Vol. 136 (6) , 585-591
Gender Equality in National Cardiology Societies: A Cross-Sectional Study
- 9 March 2023
- Published by Elsevier in The American Journal of Medicine
- Vol. 136 (6) , 585-591
Gender Equality in National Cardiology Societies: A Cross-Sectional Study
- Open Access
- 18 July 2022
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 60, 1-8
Hyponatremia in the emergency department
- 18 July 2022
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 60, 1-8
Open AccessHyponatremia in the emergency department
- Open Access
- 24 June 2022
- Published by Elsevier in Kidney Medicine
- Vol. 4 (8) , 100505
Equality in Recipients of Nephrology Awards from International Societies
- 24 June 2022
- Published by Elsevier in Kidney Medicine
- Vol. 4 (8) , 100505
Open AccessEquality in Recipients of Nephrology Awards from International Societies
- 4 May 2022
- Published by Elsevier in The American Journal of Medicine
- Vol. 135 (5) , e110-E110
The Reply
- 4 May 2022
- Published by Elsevier in The American Journal of Medicine
- Vol. 135 (5) , e110-E110
The Reply
- 7 April 2022
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 386 (14) , 1382-1384
Chlorthalidone for Hypertension in Advanced CKD
To the Editor: Agarwal and colleagues (Dec. 30 issue)1 report the findings from a trial evaluating the use of chlorthalidone as an antihypertensive agent in patients with advanced chronic kidney disease (CKD) and poorly controlled hypertension. Although the findings show the potential of chlorthalidone as a valuable add-on therapy for poorly controlled hypertension, the article lacks the necessary discussion of common and potentially harmful side effects of thiazide diuretics. In a recent cross-sectional analysis conducted in Switzerland, we showed that approximately one in five patients receiving a thiazide diuretic presented with hyponatremia or hypokalemia.2 Chlorthalidone was the thiazide diuretic with . . .
- 7 April 2022
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 386 (14) , 1382-1384
Chlorthalidone for Hypertension in Advanced CKD
To the Editor: Agarwal and colleagues (Dec. 30 issue)1 report the findings from a trial evaluating the use of chlorthalidone as an antihypertensive agent in patients with advanced chronic kidney disease (CKD) and poorly controlled hypertension. Although the findings show the potential of chlorthalidone as a valuable add-on therapy for poorly controlled hypertension, the article lacks the necessary discussion of common and potentially harmful side effects of thiazide diuretics. In a recent cross-sectional analysis conducted in Switzerland, we showed that approximately one in five patients receiving a thiazide diuretic presented with hyponatremia or hypokalemia.2 Chlorthalidone was the thiazide diuretic with . . .